课题基金 / 基金详情

CHARACTERIZATION OF THE CAPACITY LIMITED RENAL ELIMINATION OF FAMOTIDINE AND PAH

CHARACTERIZATION OF THE CAPACITY LIMITED RENAL ELIMINATION OF FAMOTIDINE AND PAH
法莫替丁和 PAH 的肾脏清除能力有限的特征
批准号:
6245675
负责人:
GARY R MATZKE
金额:
$1.76万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-18 至 1997-11-30

项目摘要

项目成果

GARY R MATZKE的其他基金

相似基金

相关文献

中文摘要
翻译
目的:建立一种有效的方法来测量功能的能力, 正常人肾小管分泌的阴离子和阳离子途径 志愿者法莫替丁和PAH将用作阳离子和阴离子 交通标志牌。 碘酞酸盐将被用作衡量 肾小球滤过率(GFR)。 这项初步研究 将包括确定肾小管转运最大值(Smax), 通过递增输注,50% Smax(EC 50)时的血浆浓度 速率,以及两种化合物的GLr/GFR比率。
英文摘要
To develop a valid method for measuring the functional capacity of the anionic and cationic pathways for renal tubular secretion in normal volunteers. Famotidine and PAH will be used as the cationic and anionic transport markers, respectively. Iothalamate will be used as the measure of glomerular filtration rate (GFR) during the study. This pilot study will include determination of the renal tubular transport maximum (Smax), the plasma concentration at 50% of Smax (EC50) through a step-up infusion rate, & the ratio GLr/GFR for both compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of Glomerular and Tubular Function
ROLE OF P GLYCOPROTEIN IN CATIONIC RENAL TUBULAR SECRETION
ROLE OF P GLYCOPROTEIN IN CATIONIC RENAL TUBULAR SECRETION
PLASMA CLEARANCE METHOD ESTIMATING GFR & ERPF
海外基金